E-LIB Suche - Ergebnisse für: Hanauer, Stephen

1

Su1809 ASSESSMENT OF STEROID USE IN PATIENTS WITH ACTIVE UL..:

Dubinsky, Marla C. ; Gianfrancesco, Milena ; Gauthier, Genevieve...
Gastroenterology. 166 (2024) 5 - p. S-823-S-824 , 2024

Link: https://doi.org/10.1016/..

2

Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy ..:

Hanauer, Stephen B. ; Sands, Bruce E. ; Schreiber, Stefan...
Gastroenterology. 167 (2024) 5 - p. 919-933 , 2024

Link: https://doi.org/10.1053/..

3

Surgery for Crohn's Disease Is Associated With a Dysbiotic ..:

Lewis, James D. ; Daniel, Scott G. ; Li, Hongzhe...
Cellular and Molecular Gastroenterology and Hepatology. 18 (2024) 3 - p. 101357 , 2024

Link: https://doi.org/10.1016/..

4

Tissue-specific reprogramming leads to angiogenic neutrophi..:

Bui, Triet M. ; Yalom, Lenore K. ; Ning, Edward...
Journal of Clinical Investigation. 134 (2024) 7 - p. , 2024

Link: https://doi.org/10.1172/..

5

Sa1784 CHARACTERIZING PRACTICE PATTERNS IN DISEASE ACTIVITY..:

Stanton, Matthew B. ; Basra, Saihej P. ; Hanauer, Stephen B..
Gastroenterology. 166 (2024) 5 - p. S-521-S-522 , 2024

Link: https://doi.org/10.1016/..

6

AMISELIMOD FOR THE TREATMENT OF ACTIVE ULCERATIVE COLITIS: ..:

Hanauer, Stephen B. ; Laitman, Adam P. ; Heimanson, Zeev...
Gastroenterology. 166 (2024) 5 - p. 492a , 2024

Link: https://doi.org/10.1016/..

7

EXPLORing the Therapeutic Ceiling in Crohn's Disease: Will ..:

Torres, Joana ; Hanauer, Stephen B.
Clinical Gastroenterology and Hepatology. 22 (2024) 7 - p. 1377-1378 , 2024

Link: https://doi.org/10.1016/..

8

COMPARATIVE EFFICACY AND SAFETY OF SUBCUTANEOUS INFLIXIMAB ..:

Sands, Bruce ; Peyrin-Biroulet, Laurent ; Schreiber, Stefan...
Inflammatory Bowel Diseases. 30 (2024) Supplement_1 - p. S4-S5 , 2024

Link: https://doi.org/10.1093/..

9

Su1762 SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) AS MAINTENANCE T..:

Hanauer, Stephen B. ; Colombel, Jean Frederic ; Sandborn, William J....
Gastroenterology. 166 (2024) 5 - p. S-802 , 2024

Link: https://doi.org/10.1016/..

10

Evolution of Symptoms After Ustekinumab Induction Therapy i..:

Colombel, Jean-Frédéric ; Sands, Bruce E. ; Gasink, Christopher...
Clinical Gastroenterology and Hepatology. 22 (2024) 1 - p. 144-153.e2 , 2024

Link: https://doi.org/10.1016/..

11

EFFICACY, SAFETY AND IMMUNOGENICITY OF SUBCUTANEOUS INFLIXI..:

Schreiber, Stefan ; Colombel, Jean-Frederic ; Hanauer, Stephen...
Inflammatory Bowel Diseases. 30 (2024) Supplement_1 - p. S8-S9 , 2024

Link: https://doi.org/10.1093/..

12

Su1828 PRECISION DOSING TEST FOR OPTIMIZING ADALIMUMAB IN I..:

Hanauer, Stephen B. ; Torres, Esther A. ; Swaminath, Arun...
Gastroenterology. 166 (2024) 5 - p. S-832 , 2024

Link: https://doi.org/10.1016/..

13

Su1821 THE ASSOCIATION BETWEEN 6-THIOGUANINE NUCLEOTIDE LEV..:

Yarur, Andres ; Abraham, Bincy P. ; Conklin, John...
Gastroenterology. 166 (2024) 5 - p. S-829 , 2024

Link: https://doi.org/10.1016/..

14

Su1755 IMPACT OF BODY MASS INDEX ON CLINICAL OUTCOMES AND D..:

Yarur, Andres ; Hanauer, Stephen B. ; Schreiber, Stefan...
Gastroenterology. 166 (2024) 5 - p. S-798-S-799 , 2024

Link: https://doi.org/10.1016/..

15

SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) DOSE ESCALATION AS AN O..:

Danese, Silvio ; Colombel, Jean-Frederic ; Hanauer, Stephen...
Inflammatory Bowel Diseases. 30 (2024) Supplement_1 - p. S00-S00 , 2024

Link: https://doi.org/10.1093/..